Janus Henderson Group PLC Cerus Corp Transaction History

Janus Henderson Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $9 - $18	6 Added 0.01%	77,250 $125,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $155 - $252	-87 Reduced 0.11%	77,244 $190,000
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $114,318 - $164,359	43,139 Added 126.17%	77,331 $229,000
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $13 - $16	-4 Reduced 0.01%	34,192 $124,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $222 - $378	65 Added 0.19%	34,196 $123,000
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $132 - $170	-30 Reduced 0.09%	34,131 $180,000
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $43 - $62	9 Added 0.03%	34,161 $188,000
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $102,528 - $136,189	17,174 Added 101.15%	34,152 $233,000
Q3 2021 Nov 16, 2021	BUY	$4.79 - $6.68 $81,324 - $113,413	16,978 New	16,978 $103,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.